Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HyClone is a leading global supplier of cell culture media, sera, and process liquids, as well as single-use systems for the biopharmaceutical industry. Originally founded in 1967, the company is renowned for its high-quality Fetal Bovine Serum (FBS) and specialized media formulations used in vaccine and protein production. Today, as a brand under Cytiva (part of Danaher), HyClone provides critical raw materials and integrated fluid management solutions that support the entire bioprocessing workflow. Their products are essential for researchers and manufacturers working in cell therapy, gene therapy, and monoclonal antibody production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HyClone.